Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata

NCT03811912 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia Areata

Interventions

DRUG: CTP-543
DRUG: CTP-543 Matching Placebo

Sponsor

Concert Pharmaceuticals